Tectonic Therapeutic Shares Hit 52-Week High After Positive Trial Data
Shares hit their 52-week high of $58.62 earlier in the session, and are now up 303% in the past 12 months. The biotechnology company said the interim data showed that a single intravenous dose of TX45 resulted in meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with group 2 pulmonary hypertension in heart failure with preserved ejection fraction.
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.
Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.
In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
Recent research paper titled "Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with ...
This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading ... Researchers Identify Over 2,000 Genetic Signals Linked to Blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback